At her 2011 Harvard University Class Day address, Amy Poehler said “You can’t do it alone. As you navigate through…
Read MoreMore Articles
Holiday greetings to all PES Members and Friends! As we close out another calendar year, one naturally considers 2023’s issues and events. The year will be most remembered for our…
Read More
Fulfilled Ighalo, MD I am currently in my second year of pediatric endocrinology fellowship at Baylor College of Medicine/Texas Children’s Hospital in Houston, Texas. I obtained my medical degree at…
Read More
Friedrich Wöhler (July 31, 1800 to September 3, 1882) and the Synthesis of Urea Submitted by Alan Rogol, MD Friedrich Wöhler was a German chemist who worked in both the…
Read More
Dr. Barry B. Bercu 1944-2023 Barry B. Bercu, M.D. died on Friday, November 24, 2023. Dr. Bercu, a pediatric endocrinologist long associated with the University of South Florida, was internationally…
Read More
Dear PES members and friends, With the advancing fall, our recent elections led to an outstanding slate of new leaders for next year. Congratulations to Laurie Cohen, Andrew Dauber, and…
Read More
Medication Shortage Alert – Pamidronate Disodium Injection: Anna Ryabets-Lienhard, DO, Drugs and Therapeutics Committee Update 10/25/23: As of August-September, there has been a national shortage of pamidronate IV injection. The…
Read More
Novo Nordisk announced on 11/8/2023 that their long-acting insulin, Levemir®, will be phased out from United States markers completely discontinuing by December 2024. It cited manufacturing constraints, reduced patient access and…
Read More
Jade Wyatt, MD I am currently a third-year pediatric endocrinology fellow at the University of North Carolina. I grew up in Texas, attended medical school at the University of Oklahoma,…
Read More
The Somatomedin and Dual Effector Theories of Growth Hormone Action Submitted by Alan D. Rogol, M.D., Ph.D. The somatomedin hypothesis stated that the uptake of sulfate in, for example rat…
Read More
New Drugs and Therapeutics Update – NGENLA By Dania Al-Hamad, MD, and Christine Yu, MD NGENLA (somatrogon-ghla), a once-weekly, human growth hormone analog, was approved by the FDA in…
Read More